Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients

MeSH terms

• Adolescent
• Adult
• Aged
• Cyclophosphamide* / administration & dosage
• Cyclophosphamide* / therapeutic use
• Cyclosporine* / therapeutic use
• Female
• Graft vs Host Disease* / prevention & control
• Hematopoietic Stem Cell Transplantation / methods
• Humans
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / therapeutic use
• Male
• Middle Aged
• Retrospective Studies
• Sirolimus* / administration & dosage
• Sirolimus* / therapeutic use